Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Advances in genomic medicine have the potential to change the way we treat human disease, but translating these advances into reality for improving healthcare outcomes depends essentially on our ability to discover disease- and/or drug-associated clinically actionable genetic mutations. Integration and manipulation of diverse genomic data and comprehensive electronic health records (EHRs) on a big data infrastructure can provide an efficient and effective way to identify clinically actionable genetic variants for personalized treatments and reduce healthcare costs. We review bioinformatics processing of next-generation sequencing (NGS) data, bioinformatics infrastructures for implementing precision medicine, and bioinformatics approaches for identifying clinically actionable genetic variants using high-throughput NGS data and EHRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
The contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585 · cited 1×
“Clinical pharmacology research using electronic health record (EHR) systems has recently become feasible as EHRs have been implemented more widely [5].”
BackgroundQuail, M., Smith, M. E., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., Bertoni, A., Swerdlow, H. P., & Gu, Y. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-341 · Cited by 2,031 · cited 2×
“Compared with other technologies, the 454 and PacBio RS platforms have demonstrated the most unbiased read distribution in genomic regions with a highGC content [41, 42], an important factor affecting the probability of calling a variant in these regions.”
MethodResultEvolution and functional impact of rare coding variation from deep sequencing of human exomes
Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G., et al. (2012) · Science · doi:10.1126/science.1219240 · Cited by 1,613 · cited 1×
“Best practices for quality control in the bioinformatics processing of NGS data have been reported in the scientific literature [45, 62].”
BackgroundDe novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496 · cited 3×
“For example, of the 12,895 unique variants with multiple clinical interpretations that have been submitted by more than one laboratory, 2,229 (17%) were interpreted differently by different submitters, with one- or two-step differences between any of three major levels: “pathogenic or likely pathogenic,” “uncertain si…”
BackgroundInfluentialGenome sequencing identifies major causes of severe intellectual disability
Gilissen, C., Hehir-Kwa, J. Y., Thung, D. T., van de Vorst, M., van Bon, B. W. M., Willemsen, M. H., Kwint, M., Janssen, I. M., Hoischen, A., Schenck, A., et al. (2014) · Nature · doi:10.1038/nature13394 · Cited by 1,125
Evaluation of next generation sequencing platforms for population targeted sequencing studies
Harismendy, O., Ng, P. C., Strausberg, R. L., Wang, X., Stockwell, T. B., Beeson, K. Y., Schork, N. J., Murray, S. S., Topol, E. J., Levy, S., et al. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r32 · Cited by 614
Improved exome prioritization of disease genes through cross-species phenotype comparison
Robinson, P. N., Köhler, S., Oellrich, A., Sanger Mouse Genetics Project, Wang, K., Mungall, C. J., Lewis, S. E., Washington, N., Bauer, S., Seelow, D., et al. (2014) · Genome Research · doi:10.1101/gr.160325.113 · Cited by 375
Saal, L. H., Vallon-Christersson, J., Häkkinen, J., Hegardt, C., Grabau, D., Winter, C., Brueffer, C., Tang, M.-H. E., Reuterswärd, C., Schulz, R., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0131-9 · Cited by 255 · cited 1×
“Advances in genomic medicine have the potential to change the way we treat human disease, but translating these advances into reality for improving healthcare outcomes depends essentially on our ability to discover disease- and/or drug-associated clinically actionable genetic mutations.”
Analysis of the Security and Privacy Requirements of Cloud-Based Electronic Health Records Systems
JPC Rodrigues, J., de la Torre, I., Fernández, G., & López-Coronado, M. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2494 · Cited by 209
Practical challenges in integrating genomic data into the electronic health record
Kho, A. N., Rasmussen, L. V., Connolly, J. J., Peissig, P. L., Starren, J., Hakonarson, H., & Hayes, M. G. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.131 · Cited by 108 · cited 1×
“However, it would require investment in data storage capacity external to the EHR database system and the development and maintenance of interfaces between the genomic databases and the EHRdatabase system [84].”
BackgroundEvaluating the Impact of Sequencing Depth on Transcriptome Profiling in Human Adipose
Liu, Y., Ferguson, J. F., Xue, C., Silverman, I. M., Gregory, B., Reilly, M. P., & Li, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066883 · Cited by 74
Cited by
Involvement of Machine Learning Tools in Healthcare Decision Making
Jayatilake, S. M. D. A. C., & Ganegoda, G. U. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/6679512 · Cited by 310
The Project Baseline Health Study: a step towards a broader mission to map human health
Arges, K., Assimes, T., Bajaj, V., Balu, S., Bashir, M. R., Beskow, L., Blanco, R., Califf, R., Campbell, P., Carin, L., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0290-y · Cited by 82
Krissaane, I., De Niz, C., Gutiérrez-Sacristán, A., Korodi, G., Ede, N., Kumar, R., Lyons, J., Manrai, A., Patel, C., Kohane, I., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa068 · Cited by 28
“27 With an eye toward enabling new biological discovery, we champion the performance benefits provided by the cloud, while emphasizing the boundaries of cluster size and utilization of computational resources.”
Background(2024) · doi:10.1038/s41592-024-02409-0 · Cited by 29
Metadata
- Authors
- Carter, T. C., & He, M. M.
- Venue
- Journal of Healthcare Engineering
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-14
- ISSN
- 2040-2295 (ISSN-L)
- 2040-2309
- OpenAlex
- W2335383608
- Cited by
- 36
- References
- 13
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.